Volker Wilhelm Stieber MD

Radiation Oncology•Winston Salem, NC

Central Nervous System Cancer, Thoracic Cancer

Physician

Join to View Full Profile

3333 Silas Creek PkwyWinston Salem, NC 27103
Phone+1 336-718-5095
Fax+1 336-718-9895

Summary

Dr. Volker Stieber is a radiation oncologist in Winston Salem, NC and is affiliated with the Novant Health Cancer Institute at Forsyth Medical Center. He is the IRB Chair and the Neuro-Oncology Council Co-Chair. He specializes in central nervous system tumors, thoracic oncology, and radiotherapy for benign conditions.

Education & Training

Mayo Clinic College of Medicine1998 - 2000
Medical University of South CarolinaResidency, Radiation Oncology, 1995 - 1998
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 1994 - 1995
Loma Linda University School of MedicineClass of 1994
University of CaliforniaBA, Biology & English, 1984 - 1988

Certifications & Licensure

NC State Medical License 2000 - 2025
SC State Medical License 1996 - 2025
CA State Medical License 1997 - 2002
FL State Medical License 1998 - 2002
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 2
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Oct 01
Completed
Phase 1
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01
Completed
Phase 2
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors Start of enrollment: 2002 Jun 01
Completed
Phase 1, Phase 2
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 Aug 01
Terminated
Phase 1, Phase 2
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer Start of enrollment: 2007 Jan 01
Withdrawn
Phase 1, Phase 2
Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
COMPLETED
PHASE1, PHASE2
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
ACTIVE_NOT_RECRUITING
NA
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825.
Joshua D Strauss, Mark R Gilbert, Minesh Mehta, Ang Li, Renke Zhou
Neuro-Oncology. 2025-03-07
5 citations
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi
Neuro-Oncology Advances. 2023-10-11
1 citations
Germline polymorphisms inassociated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman
Neuro-Oncology Advances. 2022-10-22

Press Mentions

Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory BoardFebruary 7th, 2022

Committees

Leader, Novant Health Cancer Institute GWSM Neuro-Oncology Council 2019 - Present
Chair, IRB, Novant Health Forsyth Medical Center

Professional Memberships

American Society for Radiation Oncology - ASTRO
Member
American Society of Clinical Oncology - ASCO
Member
Society for Neuro-Oncology (SNO)
Member

Other Languages

German